Dr. Bing Gong, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 68 Holland Ave, Demarest, NJ 07627 Phone: 201-658-3148 Fax: 845-703-6297 |
News Archive
CNS Protein Therapeutics, Inc., a privately held biotechnology company developing first-in-class disease–modifying treatments that address the underlying cause of cell death associated with a wide range of diseases, has completed a corporate name change to Amarantus Therapeutics, Inc. ("Amarantus") and appointed prominent biotechnology industry executive, Martin D. Cleary, as Chief Executive Officer.
Researchers at the Hebrew University of Jerusalem have discovered that a neuronal pathway - part of the autonomic nervous system - reaches the bones and participates in the control of bone development.
Human Genome Sciences, Inc. and GlaxoSmithKline PLC today announced that the U.S. Food and Drug Administration (FDA) has extended the Prescription Drug User Fee Act (PDUFA) target date for its priority review of the Biologics License Application (BLA) for BENLYSTA® (belimumab) as a potential treatment for systemic lupus erythematosus (SLE) from December 9, 2010 to March 10, 2011.
A newly developed equation produces more accurate estimates of the glomerular filtration rate (GFR) - a key indicator of kidney function in patients with chronic kidney disease (CKD), according to research being presented at the American Society of Nephrology's 41st Annual Meeting and Scientific Exposition in Philadelphia, Pennsylvania.
LipoScience, Inc., an in vitro diagnostic company advancing patient care by developing high value proprietary clinical tests using nuclear magnetic resonance (NMR) technology, announced the launch of Lipoprotein Perspectives - a medical education portal featuring experts in clinical and preventive cardiology, endocrinology, and lipidology - at www.lipoprotein.org.
› Verified 9 days ago